Another Bell Potter masterpiece. Approval would be the "most significant event " in PC since approval of gem/abr?? What, on the back of a 45 patient non-controlled safety study? Seriously who writes this tripe? Do investors actually believe these "research" notes- I'd bet the "research" in this case amounts to calling up the company for some titbits. If there's anybody from Bell potter on this forum, please go and educate yourself on LOCALLY ADVANCED PANCREATIC CANCER and what current studies show, then write a proper, credible research note! Forget 8.5months survival- that's in METASTATIC PC. All the panco trial really tells us is that adding the device to the current most effective chemo in locally advanced pC appears safe. Nothing else conclusive. And submission of post market plan is "reliable indicator" of forthcoming approval? Is that even true??
OSL Price at posting:
20.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)